Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Interim Management Statement

16 Feb 2011 07:00

RNS Number : 2938B
Volex Group PLC
16 February 2011
 



For immediate release 16 February 2011

VOLEX GROUP plc

Interim Management Statement for the 19 weeks ended 16 February 2011

Volex Group plc ('Volex' or the 'Group'), the global provider of electrical, digital and optical connections, today releases its second Interim Management Statement for the FY2011 financial year, covering the 19 weeks ended 16 February 2011.

Trading activity in the third quarter of FY2011 continued to be strong with revenue significantly ahead of the same period last year. This robust performance has continued to translate into year-on-year improvements in operating profit, despite rising commodity prices, particularly copper.

Highlights for the third quarter of FY2011 (three months to 2 January 2011) are as follows:

·; Revenue of £79.1m, up 37% on Q3 FY2010 (34% on constant currency basis)

·; Adjusted operating profit(i) of £4.0m, up 30% on Q3 FY2010 (26% on constant currency basis)

·; Cash generated by operations of £5.5m, up £3.9m (246%) on Q3 FY2010, with the improvement primarily driven by working capital efficiencies

·; Net debt of £6.0m at end of Q3 FY2011, a £1.6m (21%) reduction since the end of the last financial year and £5.3m (47%) lower than at the end of Q3 FY2010

(i) After non-recurring items but before share based payments charge

The year-on-year growth in revenue continues to be broad based with all four of our sectors (Telecom/Datacom, Healthcare, Consumer and Industrial) reporting substantial growth. Organic sales and new product development initiatives have enhanced penetration of existing accounts and are starting to generate new account wins.

Consumer sector revenue of £46.9m in Q3 was 28% up on the corresponding quarter of last year in constant currency terms. Customer demand remains high while our industry leading environmentally-friendly products (including halogen free) have continued to reinforce our strategic partnerships with key consumer electronics customers.

Revenue in the Telecom/Datacom sector of £19.1m in the third quarter represented an improvement of 28% over Q3 FY2010 in constant currency terms. Disappointingly, we have yet to see recovery in our Indian Telecom/Datacom business, however the region remains an opportunity for growth in FY2012.

Momentum in the Healthcare sector continued in Q3 FY2011, with revenue of £7.8m being 84% ahead of Q3 FY2010 on a constant currency basis. Finally, Industrial sector revenue was also strong at £5.3m in Q3 FY2011, 61% up over the same period last year on a constant currency basis.

Well-publicised increases in raw materials prices, particularly copper but also to a lesser extent oil and oil-based products, which started to impact margins and profitability in the second quarter, have had a more significant effect in Q3. In addition to rising input prices, double-digit labour rate increases have also been a factor. Management continues to be active in mitigating these rising costs, including programmes to pass through these increases to customers through price rises. However, the time lag between bearing higher input prices and selling on our products at higher prices has reduced gross margin in Q3 to 18.0%, compared to 19.6% in Q2 and 20.2% for the full year FY2010.

Adjusted operating profit of £4.0m for the quarter was 30% up on Q3 FY2010 (26% in constant currency terms).

The Group has maintained its focus on cash generation, with working capital as a % of sales in Q3 decreasing to 14.9% from 15.1% in Q2 FY2011 (and from 16.9% in Q3 FY2010). This focus has resulted in net debt reducing to £6.0m at the end of Q3 FY2011, from £10.1m at the end of Q2 FY2011 and £7.6m at the end of FY2010. This represents a significant improvement when compared to net debt at the end of Q3 FY2010 of £11.3m.

The Board is encouraged with the Group's evident resilience in the third quarter in the face of significant macro-economic challenges. The transformation we embarked on in 2008 is now paying significant dividends. Our current focus remains on addressing unprecedented cost pressures and on continuing to drive revenue and margins through enhanced customer solutions and increased Volex designed content. The Board remains confident that trading will be in line with current market expectations for the twelve months to 3 April 2011.

 

- END -

 

Volex Group plc

Ray Walsh Group Chief Executive +44 20 3370 8833

Andrew Cherry Group Finance Director +44 20 3370 8833

Buchanan Communications

Charles Ryland / Jeremy Garcia / Helen Chan +44 20 7466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSFEFMIFFSEIE
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.